AngioDynamics, Inc. (ANGO)Healthcare | Medical Instruments & Supplies | Latham, United States | NasdaqGS
12.74 USD
-0.03
(-0.274%) ⇩
(July 14, 2026, 10:03 a.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 5:28 a.m. EDT
AngioDynamics presents a classic value trap scenario where the market has priced out the business entirely due to persistent operational failures. Despite a recent revenue beat and a recovery in share price over the last year, the company remains unprofitable with negative operating margins and a forward P/E that is mathematically undefined. The balance sheet shows significant debt relative to equity, and the lack of any dividend history confirms the capital is being consumed by losses rather than returned to shareholders. The short-term outlook is neutral-to-slightly-bearish. While the stock has rallied off its lows, the technical structure remains fragile, and the statistical forecasting models offer no directional edge, reflecting the high noise-to-signal ratio in such distressed small-cap biotech plays. The options market is screaming caution, with traders buying insurance against further drops rather than betting on a rally. Long-term, the investment case is weak. The multi-year trajectory shows a brutal decline, and while the latest year saw a rebound, the underlying fundamentals—negative ROE, negative free cash flow, and a lack of sustainable profitability—do not support a 'buy and hold' thesis. The recent FDA approval for the NanoKnife is a positive catalyst, but it is insufficient to overcome the structural deterioration in the core business metrics. Investors should wait for proof of sustained profitability before considering a position. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.104291 |
| AutoARIMA | 0.111668 |
| AutoETS | 0.112537 |
| AutoTheta | 0.126890 |
| MSTL_97 | 0.156206 |
Forecast horizon: 60 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 19.20 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.209 |
| Excess Kurtosis | -0.86 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 6.573 |
| Revenue per Share | 7.588 |
| Market Cap | 526,402,976 |
| Forward P/E | -57.91 |
| Beta | 0.34 |
| Profit Margins | -10.01% |
| Website | https://www.angiodynamics.com |
As of July 11, 2026, 5:28 a.m. EDT: Speculators are positioning defensively with heavy put volume concentrated in the near term (July 17) and medium term (October 16), particularly at strikes below the current price. While there is some call interest at the $15 strike, the overwhelming open interest in out-of-the-money puts suggests a fear of downside continuation rather than a bullish breakout. Implied volatility is elevated relative to deep ITM strikes, indicating a premium for protection against further declines.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.4774567 |
| Address1 | 14 Plaza Drive |
| All Time High | 32.0 |
| All Time Low | 5.26 |
| Ask | 12.74 |
| Ask Size | 1 |
| Audit Risk | 7 |
| Average Daily Volume10 Day | 345,610 |
| Average Daily Volume3 Month | 348,645 |
| Average Volume | 348,645 |
| Average Volume10Days | 345,610 |
| Beta | 0.338 |
| Bid | 9.54 |
| Bid Size | 2 |
| Board Risk | 2 |
| Book Value | 4.159 |
| City | Latham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 3 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 12.74 |
| Current Ratio | 2.354 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 13.64 |
| Day Low | 12.31 |
| Debt To Equity | 6.573 |
| Display Name | AngioDynamics |
| Earnings Call Timestamp End | 1,784,030,400 |
| Earnings Call Timestamp Start | 1,784,030,400 |
| Earnings Timestamp | 1,784,032,200 |
| Earnings Timestamp End | 1,784,032,200 |
| Earnings Timestamp Start | 1,784,032,200 |
| Ebitda | -659,000 |
| Ebitda Margins | -0.0021 |
| Enterprise To Ebitda | -767.94 |
| Enterprise To Revenue | 1.613 |
| Enterprise Value | 506,072,800 |
| Eps Current Year | -0.22 |
| Eps Forward | -0.22 |
| Eps Trailing Twelve Months | -0.76 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 11.9472 |
| Fifty Day Average Change | 0.79279995 |
| Fifty Day Average Change Percent | 0.06635864 |
| Fifty Two Week Change Percent | 47.74567 |
| Fifty Two Week High | 13.99 |
| Fifty Two Week High Change | -1.25 |
| Fifty Two Week High Change Percent | -0.08934954 |
| Fifty Two Week Low | 8.36 |
| Fifty Two Week Low Change | 4.38 |
| Fifty Two Week Low Change Percent | 0.52392346 |
| Fifty Two Week Range | 8.36 - 13.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,086,096,600,000 |
| Float Shares | 34,610,729 |
| Forward Eps | -0.22 |
| Forward P E | -57.909092 |
| Free Cashflow | 13,942,250 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 675 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.54295 |
| Gross Profits | 170,336,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.1228 |
| Held Percent Institutions | 0.94693 |
| Implied Shares Outstanding | 41,318,915 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,748,649,600 |
| Long Business Summary | AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York. |
| Long Name | AngioDynamics, Inc. |
| Market | us_market |
| Market Cap | 526,402,976 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_4803544 |
| Most Recent Quarter | 1,772,236,800 |
| Net Income To Common | -31,387,000 |
| Next Fiscal Year End | 1,780,185,600 |
| Non Diluted Market Cap | 527,642,544 |
| Number Of Analyst Opinions | 4 |
| Open | 13.64 |
| Operating Cashflow | 4,448,000 |
| Operating Margins | -0.08198 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.41 |
| Phone | 518 795 1400 |
| Previous Close | 12.775 |
| Price Eps Current Year | -57.909092 |
| Price Hint | 2 |
| Price To Book | 3.0632365 |
| Price To Sales Trailing12 Months | 1.6779121 |
| Profit Margins | -0.10005 |
| Quick Ratio | 1.262 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.034999847 |
| Regular Market Change Percent | -0.27375713 |
| Regular Market Day High | 13.64 |
| Regular Market Day Low | 12.31 |
| Regular Market Day Range | 12.31 - 13.64 |
| Regular Market Open | 13.64 |
| Regular Market Previous Close | 12.775 |
| Regular Market Price | 12.74 |
| Regular Market Time | 1,784,037,823 |
| Regular Market Volume | 107,504 |
| Return On Assets | -0.04681 |
| Return On Equity | -0.17475 |
| Revenue Growth | 0.089 |
| Revenue Per Share | 7.588 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 41,318,915 |
| Shares Percent Shares Out | 0.032899998 |
| Shares Short | 1,357,466 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,888,850 |
| Short Name | AngioDynamics, Inc. |
| Short Percent Of Float | 0.0349 |
| Short Ratio | 3.59 |
| Source Interval | 15 |
| State | NY |
| Symbol | ANGO |
| Target High Price | 24.0 |
| Target Low Price | 16.0 |
| Target Mean Price | 18.0 |
| Target Median Price | 16.0 |
| Total Cash | 37,810,000 |
| Total Cash Per Share | 0.907 |
| Total Debt | 11,394,000 |
| Total Revenue | 313,724,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.76 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 11.57075 |
| Two Hundred Day Average Change | 1.1692495 |
| Two Hundred Day Average Change Percent | 0.10105218 |
| Type Disp | Equity |
| Volume | 107,504 |
| Website | https://www.angiodynamics.com |
| Zip | 12,110 |